Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer

被引：0
|
作者：
Li Chen
Gumuyang Zhang
Lili Xu
Xiaoxiao Zhang
Jiahui Zhang
Xin Bai
Ru Jin
Li Mao
Xin Xiao
Xiuli Li
Yi Xie
Zhengyu Jin
Hao Sun
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital
[2] Deepwise AI Lab,Department of Urology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital
[3] Deepwise Healthcare,undefined
[4] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[5] National Center for Quality Control of Radiology,undefined
来源：
Abdominal Radiology | 2023年 / 48卷
关键词：
Urinary bladder neoplasms; Tomography; X-Ray computed; Risk assessment; Algorithms; Retrospective studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 668
页数：9
相关论文
共 50 条
  • [1] Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer
    Chen, Li
    Zhang, Gumuyang
    Xu, Lili
    Zhang, Xiaoxiao
    Zhang, Jiahui
    Bai, Xin
    Jin, Ru
    Mao, Li
    Xiao, Xin
    Li, Xiuli
    Xie, Yi
    Jin, Zhengyu
    Sun, Hao
    [J]. ABDOMINAL RADIOLOGY, 2023, 48 (02) : 659 - 668
  • [2] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    [J]. INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [3] Integrating genomic alterations and histopathological features for enhanced risk stratification in non-muscle invasive bladder cancer
    Lillesand, Melinda
    Kvikstad, Vebjorn
    Gudlaugsson, Einar
    Skaland, Ivar
    Johannessen, Aida Slewa
    Tesfahun, Almaz Nigatu
    Sperstad, Sigmund Vegard
    Janssen, Emiel A. M.
    Austdal, Marie
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [4] Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer
    Ahdoot, Michael
    Theodorescu, Dan
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1345 - 1352
  • [5] Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
    Ieda, Takeshi
    Muto, Satoru
    Shimizu, Fumitaka
    Taguri, Masataka
    Yanada, Shigeto
    Kitamura, Kousuke
    Terai, Kazutaka
    Saito, Keisuke
    Ogishima, Tatsuya
    Nagata, Masayoshi
    Ide, Hisamitsu
    Okegawa, Takatsugu
    Wakumoto, Yoshiaki
    Sakamoto, Yoshiro
    Tsujimura, Akira
    Yamaguchi, Raizo
    Nutahara, Kikuo
    Horie, Shigeo
    [J]. EBIOMEDICINE, 2016, 12 : 98 - 104
  • [6] STRATIFICATION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: IMPLICATIONS FOR ADJUVANT THERAPIES
    Soria, Francesco
    D'andrea, David
    Gust, Kilian
    Gontero, Paolo
    Shariat, Shahrokh
    [J]. ANTICANCER RESEARCH, 2019, 39 (03) : 1593 - 1594
  • [7] Prognostic value of preoperative inflammation markers in non-muscle invasive bladder cancer
    Yildiz, Huseyin Alperen
    Deger, Muslim Dogan
    Aslan, Guven
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [8] Non-Muscle Invasive Bladder Cancer Preface
    Chang, Sam S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : XIII - XIII
  • [9] Immunotherapy for non-muscle invasive bladder cancer
    Cathomas, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [10] NON-MUSCLE INVASIVE BLADDER CANCER IN 2012
    Esuvaranathan, Kesavan
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 123 - 123
12345